{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,7]],"date-time":"2026-08-07T20:04:33Z","timestamp":1786133073491,"version":"build-2736575974"},"reference-count":0,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"5","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2007,5]]},"DOI":"10.1681\/asn.2007030312","type":"journal-article","created":{"date-parts":[[2007,4,11]],"date-time":"2007-04-11T20:51:00Z","timestamp":1176324660000},"page":"1368-1370","source":"Crossref","is-referenced-by-count":11,"title":["Enzyme Replacement Therapy and Fabry Kidney Disease"],"prefix":"10.1681","volume":"18","author":[{"given":"David G.","family":"Warnock","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","container-title":["Journal of the American Society of Nephrology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/00001751-200705000-00003","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,7]],"date-time":"2026-08-07T19:28:16Z","timestamp":1786130896000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/00001751-200705000-00003"}},"subtitle":["Quo Vadis?"],"short-title":[],"issued":{"date-parts":[[2007,5]]},"references-count":0,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2007]]}},"URL":"https:\/\/doi.org\/10.1681\/asn.2007030312","relation":{},"ISSN":["1046-6673"],"issn-type":[{"value":"1046-6673","type":"print"}],"subject":[],"published":{"date-parts":[[2007,5]]}}}